Prophase Labs, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OTC.Pink
ProPhase Labs seeks stockholder approval for a comprehensive digital asset and crypto treasury management strategy, alongside measures to maintain its Nasdaq listing, including a potential stock split.
OTC.Pink
ProPhase Labs has postponed its Special Meeting of Shareholders to September 9, 2025, to allow for proper dissemination of definitive proxy materials, which include proposals for a crypto treasury strategy and increased authorized shares.
OTC.Pink
ProPhase Labs, Inc. calls a Special Meeting to vote on proposals to significantly increase authorized shares, approve a large private placement, and enable a new crypto treasury strategy.
OTC.Pink
ProPhase Labs, Inc. is preparing for its 2025 Annual Meeting of Stockholders, addressing significant financial losses, a sharp decline in Total Shareholder Return, and a Nasdaq compliance issue related to its Audit Committee, while also disclosing executive compensation and related party transactions.
OTC.Pink
ProPhase Labs announces its 2024 Annual Meeting of Stockholders to be held on June 20, 2024, with key proposals including the election of directors and ratification of the independent auditor.